The passing of Washington SB 5367 in 2023 marked a turning point for the state’s cannabis and hemp marketplace. By 2025, its effects are unequivocal: the Washington State Liquor and Cannabis Board (WSLCB) now treats most hemp-derived intoxicating cannabinoids—including products with converted or synthesized THC—as regulated cannabis. This shift has fundamentally changed what can and cannot be sold at general retail versus state-licensed dispensaries, bringing significant compliance and supply-chain adjustments for operators and watchdogs alike.
This post delivers an in-depth look at how WSLCB rules (2025) interact with the evolving landscape post-SB 5367, clarifies what counts as “marijuana” versus hemp, and highlights practical, actionable steps for compliance at every node—from formulation to point of sale and beyond.
Prior to SB 5367, many hemp-derived cannabinoids—especially those manufactured or synthesized from CBD—operated in a gray market in Washington’s grocery, convenience, and online stores. Products like delta-8 and converted delta-9 gummies proliferated outside of the tightly regulated cannabis system.
With SB 5367’s passage and definitive WSLCB guidance:
Hemp (per RCW 15.140) remains federally defined as cannabis sativa with no more than 0.3% delta-9 THC by dry weight and not intended for intoxication.
Marijuana ("Cannabis" in state law) now includes any cannabis product, regardless of the original source, that:
Thus, all converted cannabinoids (often labeled as "hemp-derived THC"), as well as many consumable hemp products, now count as marijuana if intoxicating effects are possible.
The WSLCB has issued a string of enforcement bulletins and conducted regular stings/checkpoints throughout 2024 and 2025 (see bulletins). Key trends:
Many products once openly sold—like delta-8 beverages and gummies in bars and cafes—have all but vanished from general retail.
Washington’s 2025 approach to hemp-derived cannabinoids is among the strictest in the US, but clarity—at last—protects both consumers and compliant businesses. All intoxicating products, regardless of hemp or cannabis origin, now flow through the state’s regulated dispensary system. Non-cannabis retailers must act now to secure compliance and manage risks.
Need help? For real-time regulatory tracking, compliance checklists, and expert playbooks, turn to CannabisRegulations.ai. Stay ahead—protect your business and your customers with trusted intelligence.
The passing of Washington SB 5367 in 2023 marked a turning point for the state’s cannabis and hemp marketplace. By 2025, its effects are unequivocal: the Washington State Liquor and Cannabis Board (WSLCB) now treats most hemp-derived intoxicating cannabinoids—including products with converted or synthesized THC—as regulated cannabis. This shift has fundamentally changed what can and cannot be sold at general retail versus state-licensed dispensaries, bringing significant compliance and supply-chain adjustments for operators and watchdogs alike.
This post delivers an in-depth look at how WSLCB rules (2025) interact with the evolving landscape post-SB 5367, clarifies what counts as “marijuana” versus hemp, and highlights practical, actionable steps for compliance at every node—from formulation to point of sale and beyond.
Prior to SB 5367, many hemp-derived cannabinoids—especially those manufactured or synthesized from CBD—operated in a gray market in Washington’s grocery, convenience, and online stores. Products like delta-8 and converted delta-9 gummies proliferated outside of the tightly regulated cannabis system.
With SB 5367’s passage and definitive WSLCB guidance:
Hemp (per RCW 15.140) remains federally defined as cannabis sativa with no more than 0.3% delta-9 THC by dry weight and not intended for intoxication.
Marijuana ("Cannabis" in state law) now includes any cannabis product, regardless of the original source, that:
Thus, all converted cannabinoids (often labeled as "hemp-derived THC"), as well as many consumable hemp products, now count as marijuana if intoxicating effects are possible.
The WSLCB has issued a string of enforcement bulletins and conducted regular stings/checkpoints throughout 2024 and 2025 (see bulletins). Key trends:
Many products once openly sold—like delta-8 beverages and gummies in bars and cafes—have all but vanished from general retail.
Washington’s 2025 approach to hemp-derived cannabinoids is among the strictest in the US, but clarity—at last—protects both consumers and compliant businesses. All intoxicating products, regardless of hemp or cannabis origin, now flow through the state’s regulated dispensary system. Non-cannabis retailers must act now to secure compliance and manage risks.
Need help? For real-time regulatory tracking, compliance checklists, and expert playbooks, turn to CannabisRegulations.ai. Stay ahead—protect your business and your customers with trusted intelligence.